16 results
8-K
EX-99.1
DMAC
DiaMedica Therapeutics Inc.
14 Mar 22
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
4:58pm
thirty years of experience launching innovative products and building and managing commercial organizations in multiple therapeutic areas at Genentech
10-K
c9timt6saoaakn
19 Mar 19
Annual report
4:58pm
424B4
64jytni
10 Dec 18
Prospectus supplement with pricing info
4:50pm
S-1/A
tddhrxb8zaosl3 08
19 Nov 18
IPO registration (amended)
5:01pm
S-1
ja43ehp7u5bt owz417
9 Nov 18
IPO registration
4:21pm
DRS
ka8o tr1k7pz31
1 Nov 18
Draft registration statement
12:00am
DRS/A
sxf096ji7
19 Oct 18
Draft registration statement (amended)
12:00am
20FR12B/A
ppw3x
11 Mar 14
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
98hsr
30 Jan 14
Initial registration of securities (foreign private issuers)
12:00am
- Prev
- 1
- Next